Mitoxantrone and high-dose cytarabine as salvage therapy for refractory non-Hodgkin's lymphoma
Open Access
- 1 October 1989
- Vol. 64 (7), 1388-1392
- https://doi.org/10.1002/1097-0142(19891001)64:7<1388::aid-cncr2820640703>3.0.co;2-0
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Combination of mitoxantrone and etoposide in refractory acute myelogenous leukemia--an active and well-tolerated regimen.Journal of Clinical Oncology, 1988
- High-dose cytosine arabinoside and mitoxantrone: a highly effective regimen in refractory acute myeloid leukemiaBlood, 1987
- Mitoxantrone: A New Anticancer Drug with Significant Clinical ActivityAnnals of Internal Medicine, 1986
- Mitoxantrone alone and in combination with cytosine arabinoside in refractory Hodgkin's and non- Hodgkin-lymphomaZeitschrift für Krebsforschung und Klinische Onkologie, 1986
- High-dose cytosine arabinoside in previously treated patients with poor-prognosis non-Hodgkin's lymphomaCancer, 1985
- High-dose cytosine arabinosideAmerican Journal Of Medicine, 1984
- Mitoxantrone hydrochloride in lymphomaCancer Treatment Reviews, 1983
- High-dose cytosine arabinoside in non-Hodgkin's lymphoma.Journal of Clinical Oncology, 1983
- Sequential chemotherapy and late intensification for malignant lymphomas of aggressive histologic typeAmerican Journal Of Medicine, 1983
- Combination Chemotherapy of Advanced Diffuse Histiocytic Lymphoma with the Six-Drug COP-BLAM RegimenAnnals of Internal Medicine, 1982